Harmon J T, Jamieson G A
Ann N Y Acad Sci. 1986;485:387-95. doi: 10.1111/j.1749-6632.1986.tb34599.x.
Computer-assisted data analysis of binding isotherms (LIGAND) has shown that human platelets have binding sites for alpha-thrombin of high (Kd 0.3 nM), moderate (Kd 10 nM), and low affinities (Kd 3 microM). Application of similar techniques has shown that TLCK-thrombin does not, whereas PPACK-thrombin does, bind to the high-affinity binding site accessible to alpha-thrombin, but that both bind to the moderate and low-affinity sites. Treatment of platelets with Serratia marcescens protease destroys the high-affinity site but does not affect moderate-affinity binding. In accordance with this model, both modified thrombins compete with alpha-thrombin for platelet activation at the moderate-affinity site, but only PPACK-thrombin competes at the high-affinity site. These results establish that platelet activation by either low or moderate concentrations of thrombin are receptor-mediated events and explain the paradox of the differential effects of TLCK-thrombin on the binding and activation of platelets by alpha-thrombin.
对结合等温线的计算机辅助数据分析(LIGAND程序)表明,人血小板具有高亲和力(解离常数Kd为0.3 nM)、中等亲和力(Kd为10 nM)和低亲和力(Kd为3 μM)的α-凝血酶结合位点。应用类似技术表明,甲苯磺酰-L-赖氨酸氯甲基酮凝血酶(TLCK-凝血酶)不能结合α-凝血酶可及的高亲和力结合位点,而苯甲脒基丙酰基-精氨酰-氯甲基酮凝血酶(PPACK-凝血酶)可以,但二者均可结合中等亲和力和低亲和力位点。用粘质沙雷氏菌蛋白酶处理血小板会破坏高亲和力位点,但不影响中等亲和力结合。根据该模型,两种修饰的凝血酶在中等亲和力位点与α-凝血酶竞争血小板激活,但只有PPACK-凝血酶在高亲和力位点竞争。这些结果表明,低浓度或中等浓度凝血酶引起的血小板激活是受体介导的事件,并解释了TLCK-凝血酶对α-凝血酶结合和激活血小板产生不同作用这一矛盾现象。